Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
OMNICELL, INC.
Report date June 15, 2023 · Filed June 16, 2023
Section 16 reporting ended · disclosed 2023-06-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,720 |
Reported balance
After 2023-06-15 transaction · row 1
1 source rowRow 1 · 2023-06-15 · Tax withholding · Disposed 3,068 · Balance 26,720 F1: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2023 Filed Jun 16, 2023 20:10 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 3,068 | $72.32 | $221,877.76 |
DisclosureSEC source: 0001415889-23-009927 · form4-06162023_080625.xml · nonDerivative · entry 1 Seidelmann Scott Peter · CIK 0001736895 · EVP, EXECUTIVE ADVISOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,720 F1 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. Read SEC document |
| December 27, 2022 Filed Dec 29, 2022 21:16 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 945 | $48.28 | $45,624.60 |
DisclosureSEC source: 0001415889-22-013061 · form4-12292022_091203.xml · nonDerivative · entry 1 Seidelmann Scott Peter · CIK 0001736895 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,788 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021 as amended on August 31, 2022. F2 · price: The price reported in Column 4 is an exact price of $48.28 for all shares sold. Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 22:08 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 1,250 | $48.09 | $60,110.00 |
DisclosureSEC source: 0001415889-22-012743 · form4-12192022_101246.xml · nonDerivative · entry 3 Seidelmann Scott Peter · CIK 0001736895 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,733 F2 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021 as amended on August 31, 2022. F4 · price: The price reported in Column 4 is a weighted average price of $48.0880. The sold price range between $48.00 to $48.22. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 22:08 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 3,186 | $47.67 | $151,879.81 |
DisclosureSEC source: 0001415889-22-012743 · form4-12192022_101246.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,983 F2 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021 as amended on August 31, 2022. F3 · price: The price reported in Column 4 is a weighted average price of $47.6710. The sold price range between $47.08 to $47.98. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 22:08 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 3,827 | $48.44 | $185,379.88 |
DisclosureSEC source: 0001415889-22-012743 · form4-12192022_101246.xml · nonDerivative · entry 1 Seidelmann Scott Peter · CIK 0001736895 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,169 F1 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. Read SEC document |
| November 28, 2022 Filed Nov 30, 2022 22:26 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 1,793 | $51.46 | $92,267.78 |
DisclosureSEC source: 0001415889-22-011856 · form4-11302022_101124.xml · nonDerivative · entry 1 Seidelmann Scott Peter · CIK 0001736895 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,996 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021 as amended on August 31, 2022. F2 · price: The price reported in Column 4 is an exact price of $51.46 for all shares sold. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 21:11 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 550 | $111.02 | $61,060.67 |
DisclosureSEC source: 0001415889-22-006768 · form4-06172022_020631.xml · nonDerivative · entry 4 Seidelmann Scott Peter · CIK 0001736895 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,789 F2 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. F5 · price: The price reported in Column 4 is a weighted average price of $111.0194. The sold price range between $110.64 to $111.25. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 21:11 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 3,208 | $110.01 | $352,911.76 |
DisclosureSEC source: 0001415889-22-006768 · form4-06172022_020631.xml · nonDerivative · entry 3 Seidelmann Scott Peter · CIK 0001736895 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,339 F2 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. F4 · price: The price reported in Column 4 is a weighted average price of $110.0099. The sold price range between $109.59 to $110.58. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 21:11 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 7 | $108.56 | $759.92 |
DisclosureSEC source: 0001415889-22-006768 · form4-06172022_020631.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,547 F2 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. F3 · price: The price reported in Column 4 is an exact price of $108.56 for all shares sold. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 21:11 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 3,826 | $113.11 | $432,758.86 |
DisclosureSEC source: 0001415889-22-006768 · form4-06172022_020631.xml · nonDerivative · entry 1 Seidelmann Scott Peter · CIK 0001736895 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,554 F1 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. Read SEC document |
| March 16, 2022 Filed Mar 16, 2022 20:29 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 2,525 | $133.11 | $336,102.75 |
DisclosureSEC source: 0001179110-22-002278 · edgar.xml · nonDerivative · entry 4 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,380 F3 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9,2021. F4 · price: The price reported in Column 4 is an exact price of $133.11 for all shares sold. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 20:29 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 2,235 | $131.21 | $293,254.35 |
DisclosureSEC source: 0001179110-22-002278 · edgar.xml · nonDerivative · entry 3 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,905 F2 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of performance-based restricted stock units. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 20:29 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 19,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-002278 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,140 F1 · shares: Reflects performance-based restricted stock units that were previously granted on February 9, 2021 subject to the Company meeting certain stock performance objectives compared to the NASDAQ Healthcare Index, as previously reported at the target amount of 9,520 shares on Form 4 filed on February 11, 2021. On March 14, 2022 (the determination date), the Compensation Committee determined the performance criteria was met with respect to 19,040 performance-based restricted stock units (200% of target) of which 25% vested upon the determination date. The remaining performance-based restricted stock units will vest on a semi-annual basis over a period of thirty-six months commencing on June 15, 2022. F1 · balance_after: Reflects performance-based restricted stock units that were previously granted on February 9, 2021 subject to the Company meeting certain stock performance objectives compared to the NASDAQ Healthcare Index, as previously reported at the target amount of 9,520 shares on Form 4 filed on February 11, 2021. On March 14, 2022 (the determination date), the Compensation Committee determined the performance criteria was met with respect to 19,040 performance-based restricted stock units (200% of target) of which 25% vested upon the determination date. The remaining performance-based restricted stock units will vest on a semi-annual basis over a period of thirty-six months commencing on June 15, 2022. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 23:32 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 9,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-001404 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,620 F1 · shares: RSU: Restricted Stock Units shall vest semiannually on 6/15 and 12/15 for a period of 4 years Read SEC document |
| December 16, 2021 Filed Dec 16, 2021 22:57 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 450 | $178.69 | $80,410.50 |
DisclosureSEC source: 0001179110-21-011069 · edgar.xml · nonDerivative · entry 6 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,632 F2 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on Sept 9,2021. F6 · price: The price reported in Column 4 is a weighted average price of $178.69. The shares were sold in multiple transactions at prices ranging from $178.30 to $179.01. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| December 16, 2021 Filed Dec 16, 2021 22:57 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 550 | $177.59 | $97,674.50 |
DisclosureSEC source: 0001179110-21-011069 · edgar.xml · nonDerivative · entry 5 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,082 F2 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on Sept 9,2021. F5 · price: The price reported in Column 4 is a weighted average price of $177.59. The shares were sold in multiple transactions at prices ranging from $177.29 to $178.28. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| December 16, 2021 Filed Dec 16, 2021 22:57 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 1,689 | $176.69 | $298,429.41 |
DisclosureSEC source: 0001179110-21-011069 · edgar.xml · nonDerivative · entry 4 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,632 F2 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on Sept 9,2021. F4 · price: The price reported in Column 4 is a weighted average price of $176.69. The shares were sold in multiple transactions at prices ranging from $176.25 to $177.21. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| December 16, 2021 Filed Dec 16, 2021 22:57 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 939 | $176.00 | $165,264.00 |
DisclosureSEC source: 0001179110-21-011069 · edgar.xml · nonDerivative · entry 3 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,321 F2 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on Sept 9,2021. F3 · price: The price reported in Column 4 is a weighted average price of $176.00. The shares were sold in multiple transactions at prices ranging from $175.23 to $176.19. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 22:57 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 3,129 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-011069 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,260 F1 · price: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| August 05, 2021 Filed Aug 6, 2021 21:48 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 38,250 | $38,250.00 Strike: $43.30 | $1,463,062,500.00 |
DisclosureSEC source: 0001179110-21-008004 · edgar.xml · derivative · entry 7 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires 2028-04-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2021 Filed Aug 6, 2021 21:48 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 658 | $153.58 | $101,052.42 |
DisclosureSEC source: 0001179110-21-008004 · edgar.xml · nonDerivative · entry 6 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,389 F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $153.37 to $154.02. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| August 05, 2021 Filed Aug 6, 2021 21:48 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 2,970 | $152.96 | $454,282.29 |
DisclosureSEC source: 0001179110-21-008004 · edgar.xml · nonDerivative · entry 5 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,047 F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.58 to $153.23. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| August 05, 2021 Filed Aug 6, 2021 21:48 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 4,774 | $153.62 | $733,393.34 |
DisclosureSEC source: 0001179110-21-008004 · edgar.xml · nonDerivative · entry 4 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,017 F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $153.50 to $154.02. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| August 05, 2021 Filed Aug 6, 2021 21:48 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 33,476 | $152.96 | $5,120,562.61 |
DisclosureSEC source: 0001179110-21-008004 · edgar.xml · nonDerivative · entry 3 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,791 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.5060 to $153.47. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| August 05, 2021 Filed Aug 6, 2021 21:48 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 38,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-008004 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,267 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 17:23 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 3,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006761 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,017 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 23:10 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 771 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002729 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,147 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 21:43 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 9,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-001587 · edgar.xml · nonDerivative · entry 3 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,918 F2 · shares: The Performance-based restricted stock unit awards vest as to 25% of the shares on the date of the Compensation Committee meeting in 2022 when the Committee reviews the performance-based metrics and determines if they were met or not with the remaining shares vesting on a semi-annual basis over a period of thirty-six months commencing on June 15, 2022 if the Company meets certain stock performance objectives compared to the NASDAQ Healthcare Index. The actual number of performance based stock awards that vest may be 0%, 50% or 100% or 150% or 200% of the numbers reflected above, depending upon the Company's performance. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 21:43 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 11,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-001587 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,398 F1 · shares: RSU: Restricted Stock Units shall vest semiannually on 6/15 and 12/15 for a period of 4 years Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 21:16 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 100 | $116.05 | $11,605.00 |
DisclosureSEC source: 0001179110-20-012048 · edgar.xml · nonDerivative · entry 4 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,048 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F4 · shares: The price reported in Column 4 is the average price of $116.05. The sold shares for the exact price. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · price: The price reported in Column 4 is the average price of $116.05. The sold shares for the exact price. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 21:16 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 1,725 | $115.68 | $199,551.11 |
DisclosureSEC source: 0001179110-20-012048 · edgar.xml · nonDerivative · entry 3 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,148 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · shares: The price reported in Column 4 is the average price of $115.6818. The sold price range between $115.02 to $116.00. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · price: The price reported in Column 4 is the average price of $115.6818. The sold price range between $115.02 to $116.00. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 21:16 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 300 | $114.13 | $34,239.00 |
DisclosureSEC source: 0001179110-20-012048 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,873 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F1 · shares: The price reported in Column 4 is the average price of $114.13. The sold price range between $113.95 to $114.49. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · price: The price reported in Column 4 is the average price of $114.13. The sold price range between $113.95 to $114.49. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 17:55 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 2,087 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-011970 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,173 F1 · price: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 21:09 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 1,025 | $67.99 | $69,688.11 |
DisclosureSEC source: 0001179110-20-007502 · edgar.xml · nonDerivative · entry 3 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,260 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · price: The price reported in Column 4 is the average price of $67.9884. The sold price range between $67.74 to $68.74. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 21:09 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 1,100 | $67.44 | $74,181.03 |
DisclosureSEC source: 0001179110-20-007502 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,285 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F1 · price: The price reported in Column 4 is the average price of $67.4373. The sold price range between $66.74 to $67.70. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 19:29 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 2,087 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-007411 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,385 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 19:15 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 809 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-003033 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,472 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 19:39 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantStock Options NQ (Right to Buy) · Derivative | 25,618 | $0.00 Strike: $90.19 | $0.00 |
DisclosureSEC source: 0001179110-20-001740 · edgar.xml · derivative · entry 4 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,618 Underlying: Common Stock · 25,618 shares Expires 2030-02-12 F3 · shares: NQ: Shares shall vest ratably over 48 month period, with a year cliff. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 19:39 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 5,987 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-001740 · edgar.xml · nonDerivative · entry 3 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,281 F2 · shares: RSU: Restricted Stock Units shall vest semiannually on 6/15 and 12/15 for a period of 4 years. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 19:39 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 6,653 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-001740 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,294 F1 · shares: The Performance-based restricted stock unit awards vest as to 25% of the shares on the date of the Compensation Committee meeting in 2021 when the Committee reviews the performance-based metrics and determines if they were met or not with the remaining shares vesting on a semi-annual basis over a period of thirty-six months commencing on June 15, 2021 if the Company meets certain stock performance objectives compared to the NASDAQ Healthcare Index. The actual number of performance based stock awards that vest may be 0%, 50% or 100% of the numbers reflected above, depending upon the Company's performance. Read SEC document |
| February 10, 2020 Filed Feb 11, 2020 17:16 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 2,833 | $0.00 Strike: $43.30 | $0.00 |
DisclosureSEC source: 0001179110-20-001435 · edgar.xml · derivative · entry 6 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,833 shares Expires 2028-04-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| February 10, 2020 Filed Feb 11, 2020 17:16 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 584 | $87.31 | $50,986.82 |
DisclosureSEC source: 0001179110-20-001435 · edgar.xml · nonDerivative · entry 5 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,641 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F4 · price: The price reported in Column 4 is the average price of $87.3062. The sold price range between $87.16 to $87.45. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 10, 2020 Filed Feb 11, 2020 17:16 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 1,649 | $86.58 | $142,767.45 |
DisclosureSEC source: 0001179110-20-001435 · edgar.xml · nonDerivative · entry 4 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,225 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F3 · price: The price reported in Column 4 is the average price of $86.5782. The sold price range between $86.07 to $87.04. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 10, 2020 Filed Feb 11, 2020 17:16 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 600 | $84.91 | $50,943.96 |
DisclosureSEC source: 0001179110-20-001435 · edgar.xml · nonDerivative · entry 3 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,874 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · price: The price reported in Column 4 is the average price of $84.9066. The sold price range between $84.58 to $85.42. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 10, 2020 Filed Feb 11, 2020 17:16 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 2,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-001435 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| December 16, 2019 Filed Dec 16, 2019 21:47 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 1,356 | $80.59 | $109,281.40 |
DisclosureSEC source: 0001179110-19-012830 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,641 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F1 · price: The price reported in Column 4 is the average price of $80.5910. The sold price range between $80.22 to $80.94. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 15, 2019 Filed Dec 16, 2019 20:04 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 1,336 | $79.69 | $106,465.84 |
DisclosureSEC source: 0001179110-19-012780 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,997 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| November 15, 2019 Filed Nov 15, 2019 22:50 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 2,833 | $0.00 Strike: $43.30 | $0.00 |
DisclosureSEC source: 0001179110-19-011764 · edgar.xml · derivative · entry 4 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,833 shares Expires 2028-04-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| November 15, 2019 Filed Nov 15, 2019 22:50 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 2,833 | $75.00 | $212,475.00 |
DisclosureSEC source: 0001179110-19-011764 · edgar.xml · nonDerivative · entry 3 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,333 F2 · price: The price reported in Column 4 is the average price of $75.00. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 15, 2019 Filed Nov 15, 2019 22:50 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 2,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-011764 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.